Greyson’s Trilexon® System Receives Trademark Approval

Greyson’s Trilexon® System Receives Trademark Approval

Boca Raton, Fla. – April 21, 2009 — GREYSON INTERNATIONAL, INC. (GYSN.PK) has been awarded trademark approval for Trilexon®, a new delivery system which will improve the effectiveness of virtually every topical application in today’s cosmetic market and every over-the-counter topical drug application.

The first products featuring the Trilexon® system are skin-care products that are currently in the preparation stage to be sold in the marketplace.

“We are pleased to announce that Trilexon® is now a registered trademark of Greyson International,” said Greyson International President and CEO Harvey Tauman. “This is a very important step for us as we move forward from the developmental and research stage into the marketing and sales stage for Greyson’s products and applications.”

About Greyson International, Inc.
Greyson International, Inc. is a research, development and marketing company that markets health and beauty aid products. Greyson has developed a new delivery method, the Trilexon® system, which will improve the effectiveness of virtually every topical application in today’s cosmetic market and every over-the-counter topical drug application. Trilexon® is a registered trademark of Greyson International. For more information, visit www.greysonproducts.com.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.